Shili Xu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Molecular cancer therapeutics

Proceedings of the National Academy of Sciences of the United States of America

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

University of Michigan

University of Southern California (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan

United States

Postdoctoral Research Fellow / Lab Manager :: Medicinal Chemistry

Novo Nordisk

China

Summer Intership :: R & D center

Education History

University of Southern California

United States

PHD :: Pharmacology and Pharmaceutical Sciences

Peking University

China

BSC :: Biological Sciences

Publications

Michael Chen, Natalia Neverova, Shili Xu, Krit Suwannaphoom, Gentian Lluri, Mikayla Tamboline, Sandra Duarte, Michael C Fishbein, Yuan Luo, René R Sevag Packard
Invasive electrochemical impedance spectroscopy with phase delay for experimental atherosclerosis phenotyping. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (10) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics (2024)
Michael Chen, Natalia Neverova, Shili Xu, Krit Suwannaphoom, Gentian Lluri, Mikayla Tamboline, Sandra Duarte, Michael C Fishbein, Yuan Luo, René R Sevag Packard
Invasive electrochemical impedance spectroscopy with phase delay for experimental atherosclerosis phenotyping. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (10) (2024)
Liu Yang, Xiaowei Yan, Jie Chen, Qiong Zhan, Yingqi Hua, Shili Xu, Ziming Li, Zhuo Wang, Yu Dong, Dongqing Zuo, Min Xue, Yin Tang, Harvey R Herschman, Shun Lu, Qihui Shi, Wei Wei
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Irmina A Elliott, Amanda M Dann, Shili Xu, Stephanie S Kim, Evan R Abt, Woosuk Kim, Soumya Poddar, Alexandra Moore, Lei Zhou, Jennifer L Williams, Joseph R Capri, Razmik Ghukasyan, Cynthia Matsumura, D Andrew Tucker, Wesley R Armstrong, Anthony E Cabebe, Nanping Wu, Luyi Li, Thuc M Le, Caius G Radu, Timothy R Donahue
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Proceedings of the National Academy of Sciences of the United States of America 116 (14) (2019)

Shili Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shili Xu